Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
Protagonist Therapeutics, Inc. (PTGX)
Today's Latest Price: $19.97 USD
Updated Sep 25 4:00pm
Add PTGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PTGX Stock Summary
- Of note is the ratio of Protagonist Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 9.35% of US stocks have a lower such ratio.
- PTGX's price/sales ratio is 43.95; that's higher than the P/S ratio of 95.46% of US stocks.
- Revenue growth over the past 12 months for Protagonist Therapeutics Inc comes in at 808.42%, a number that bests 99.01% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Protagonist Therapeutics Inc, a group of peers worth examining would be MORF, MGNX, VBLT, XENE, and CRBP.
- PTGX's SEC filings can be seen here. And to visit Protagonist Therapeutics Inc's official web site, go to www.protagonist-inc.com.
PTGX Stock Price Chart Technical Analysis Charts
PTGX Price/Volume Stats
| Current price | $19.97 | 52-week high | $23.25 |
| Prev. close | $19.43 | 52-week low | $4.47 |
| Day low | $19.04 | Volume | 217,786 |
| Day high | $20.18 | Avg. volume | 532,085 |
| 50-day MA | $19.06 | Dividend yield | N/A |
| 200-day MA | $12.49 | Market Cap | 735.04M |
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
Loading social stream, please wait...